Bank of Montreal closed 9.3% short of its 52-week high of C$151.08, which the company reached on February 25th.

Shares of Bank of Montreal BMO rose 1.53% to C$139.41 Wednesday, in what proved to be an all-around favorable trading session ...

but may initiate a beneficial Long position through a purchase of the stock, or the purchase of call options or similar derivatives in BMO over the next 72 hours. I wrote this article myself ...

BMO Capital analyst Kostas Biliouris initiated coverage of Dyne Therapeutics (DYN) with an Outperform rating and $50 price target The firm ...

BMO Capital initiated coverage of Avidity Biosciences (RNA) with an Outperform rating and $72 price target Avidity’s pipeline includes ...

SVNLY currently has a PEG ratio of 2.07. Another notable valuation metric for BMO is its P/B ratio of 1.27. The P/B ratio is used to compare a stock's market value with its book value, which is ...

The firm owned 7,833 shares of the bank’s stock after acquiring an additional 3,502 shares during the quarter. Jones Financial Companies Lllp’s holdings in Bank of Montreal were worth $760,000 ...

Fintel reports that on March 12, 2025, BMO Capital initiated coverage of Dyne Therapeutics (NasdaqGS:DYN) with a Outperform ...

These dividend stocks will consistently pay and increase their dividends, making them attractive investment to generate passive income.

Fintel reports that on March 12, 2025, BMO Capital initiated coverage of Avidity Biosciences (NasdaqGM:RNA) with a Outperform ...

The BMO Capital analyst’s reiteration of the Outperform ... Trading at a P/E ratio of 48.5, the stock is currently valued above its InvestingPro Fair Value. Investors seeking deeper insights ...

Other equities analysts have also issued reports about the stock. Cibc World Mkts upgraded shares of Bank of Montreal from a “hold” rating to a “strong-buy” rating in a report on Friday ...